奥希替尼诱发的Takotsubo心肌病复发：一例报告
Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report.
作者信息
Fukuda Yuko, Kawa Yoshitaka, Nonaka Akiko, Shiotani Hideyuki
机构信息
Division of Onco-cardiology Hyogo cancer center Akashi Japan.
Division of Respiratory Medicine Hyogo cancer center Akashi Japan.
出版信息
Clin Case Rep. 2022 Sep 2;10(9):e6279. doi: 10.1002/ccr3.6279. eCollection 2022 Sep.
Abstract
A patient with lung cancer was administrated osimertinib. She developed symptomatic heart failure due to Takotsubo cardiomyopathy (TC). As her condition improved after discontinuing osimertinib, TC was thought to be caused by osimertinib. Reoccurrence of TC was seen after readministrating half dose of osimertinib.
摘要
一名肺癌患者接受了奥希替尼治疗。她因应激性心肌病（TC）出现了有症状的心力衰竭。由于停用奥希替尼后她的病情有所改善，所以认为TC是由奥希替尼引起的。再次给予半剂量奥希替尼后，出现了TC复发。
Zotero 插件